| scholarly article | Q13442814 |
| P2093 | author name string | de Beer FC | |
| Coetzee GA | |||
| van der Westhuyzen DR | |||
| Hoppe HC | |||
| Jeenah MS | |||
| Strachan AF | |||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 9644-9651 | |
| P577 | publication date | 1986-07-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition | |
| P478 | volume | 261 |
| Q28252254 | A brief elevation of serum amyloid A is sufficient to increase atherosclerosis |
| Q36459901 | A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins |
| Q36558328 | A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells |
| Q34503409 | ATP binding cassette G1-dependent cholesterol efflux during inflammation |
| Q33389832 | Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages |
| Q52594223 | An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. |
| Q24798517 | Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production? |
| Q24322583 | Apolipoproteins A-I and A-II downregulate neutrophil functions |
| Q92598907 | Association of acute Babesia canis infection and serum lipid, lipoprotein, and apoprotein concentrations in dogs |
| Q36985703 | Associations of SAA1 gene polymorphism with lipid lelvels and osteoporosis in Chinese women |
| Q37153132 | Associations of genetic polymorphisms of SAA1 with cerebral infarction |
| Q34546651 | Autoimmune‐mediated reduction of high‐density lipoprotein–cholesterol and paraoxonase 1 activity in systemic lupus erythematosus–prone gld mice |
| Q28580132 | CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells |
| Q36546997 | COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link. |
| Q46969698 | Changes in plasma LDL and HDL composition in patients undergoing cardiac surgery |
| Q39677539 | Cytokine-responsive induction of SAF-1 activity is mediated by a mitogen-activated protein kinase signaling pathway |
| Q38577283 | Dysfunctional HDL and atherosclerotic cardiovascular disease |
| Q34727869 | Dysfunctional high-density lipoprotein |
| Q64069819 | Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells |
| Q41759940 | Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein. |
| Q33911023 | Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissue |
| Q92113184 | Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages |
| Q24563622 | Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function |
| Q42159999 | Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis |
| Q34185567 | Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome |
| Q55420511 | HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients. |
| Q57157407 | HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock |
| Q42580907 | HDL remodeling during the acute phase response |
| Q38076113 | High density lipoproteins and atherosclerosis: emerging aspects. |
| Q36015473 | High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration |
| Q36213854 | High-capacity selective uptake of cholesteryl ester from native LDL during macrophage foam cell formation |
| Q37696936 | High-density lipoprotein and the acute phase response |
| Q89433895 | High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation |
| Q36610592 | High-density lipoproteins and the immune system |
| Q34876325 | Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI. |
| Q42017597 | Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production |
| Q24527338 | Human serum amyloid A protein. Complete amino acid sequence of a new variant |
| Q35146801 | Human serum amyloid A3 (SAA3) protein, expressed as a fusion protein with SAA2, binds the oxidized low density lipoprotein receptor. |
| Q50990163 | Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A2 (sPLA2). |
| Q42792501 | Identification of a novel serum amyloid A protein in BALB/c mice |
| Q42074154 | Identification of three isoform patterns of human serum amyloid A protein |
| Q36826344 | Immunization with pneumococcal polysaccharide serotype 3 and lipopolysaccharide modulates lung and liver inflammation during a virulent Streptococcus pneumoniae infection in mice |
| Q42875712 | Immunomodulatory role of high-density lipoproteins: impact on immunosenescence |
| Q39626162 | Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome. |
| Q36930176 | Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice |
| Q34187954 | Impact of serum amyloid A on high density lipoprotein composition and levels |
| Q40251623 | Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients |
| Q35886286 | Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity |
| Q33675323 | Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry |
| Q33743503 | Intestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis |
| Q64123453 | Intestinal Serum amyloid A suppresses systemic neutrophil activation and bactericidal activity in response to microbiota colonization |
| Q39576899 | Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter |
| Q37210613 | Lipid management: considerations in acute coronary syndrome |
| Q37396588 | Lipid management: considerations in acute coronary syndrome |
| Q36648784 | Lipoproteins in inflammation and sepsis. II. Clinical aspects. |
| Q41231925 | Liver disease alters high-density lipoprotein composition, metabolism and function |
| Q33945076 | Minimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation |
| Q37171830 | Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages |
| Q33741235 | Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2) |
| Q35561979 | Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase |
| Q35747771 | Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI. |
| Q42118250 | Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. |
| Q27309035 | No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic mice |
| Q35022915 | Organization and biology of the porcine serum amyloid A (SAA) gene cluster: isoform specific responses to bacterial infection |
| Q27006749 | Paired measurements of paraoxonase 1 and serum amyloid A as useful disease markers |
| Q41980290 | Phosphorylation of human serum amyloid A protein by protein kinase C. |
| Q34786054 | Phytosterols differentially influence ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells |
| Q40083837 | Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction. |
| Q33754627 | Polymorphisms in the SAA1/2 Gene Are Associated with Carotid Intima Media Thickness in Healthy Han Chinese Subjects: The Cardiovascular Risk Survey |
| Q37683292 | Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis |
| Q33752486 | Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function |
| Q33385956 | Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease |
| Q34053599 | Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry |
| Q28281545 | Regulation of serum amyloid A protein expression during the acute-phase response |
| Q28279562 | SAA does not induce cytokine production in physiological conditions |
| Q35886240 | SAA: a link between cholesterol efflux capacity and inflammation? |
| Q41856759 | SR-BI selective lipid uptake: subsequent metabolism of acute phase HDL. |
| Q24299462 | Scavenger receptor SR-BI in macrophage lipid metabolism |
| Q33581415 | Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism |
| Q64120764 | Serum Amyloid A Stimulates Vascular and Renal Dysfunction in Apolipoprotein E-Deficient Mice Fed a Normal Chow Diet |
| Q47287451 | Serum Amyloid A3 is a High-Density Lipoprotein-associated Acute Phase Protein |
| Q62640193 | Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation |
| Q35087226 | Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans |
| Q36430779 | Serum amyloid A impairs the antiinflammatory properties of HDL |
| Q41874207 | Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. |
| Q47205995 | Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response |
| Q37061136 | Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner |
| Q38761950 | Serum amyloid A1: Structure, function and gene polymorphism |
| Q33418206 | Serum amyloid A3 does not contribute to circulating SAA levels |
| Q57420160 | Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition |
| Q47136149 | Sports and HDL-Quality Reflected By Serum Amyloid A and Surfactant Protein B. |
| Q33604867 | Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults |
| Q36723137 | Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks. |
| Q41198784 | Systems Analysis of the Complement-Induced Priming Phase of Liver Regeneration. |
| Q36610558 | The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A. |
| Q41295530 | The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection. |
| Q35886290 | Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL. |
| Q35018226 | Thorough investigation of a canine autoinflammatory disease (AID) confirms one main risk locus and suggests a modifier locus for amyloidosis. |
| Q33742998 | Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3. |
| Q35210194 | Uremia alters HDL composition and function |
Search more.